Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs (Q48004365)

7 February 2018

title

Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs (English)

1 reference

7 February 2018

0 references

1 reference

foot-and-mouth disease

1 reference

1 reference

7 February 2018

author name string

M M Harmsen

1 reference

7 February 2018

H P D Fijten

1 reference

7 February 2018

B Engel

1 reference

7 February 2018

A Dekker

1 reference

7 February 2018

language of work or name

English

0 references

publication date

31 January 2009

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

1904-1911

1 reference

7 February 2018

Molecular epidemiology of foot-and-mouth disease virus.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

History of the control of foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Properties, production, and applications of camelid single-domain antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Increased heterologous protein production by Saccharomyces cerevisiae growing on ethanol as sole carbon source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Validation of a LightCycler-based reverse transcription polymerase chain reaction for the detection of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Immunogenicity of protein therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.110

10.1016/J.VACCINE.2009.01.110

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018